Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.

about

Sarcopenia in resected non-small cell lung cancer: let's move to patient-directed strategies

P2860

Q58128727-BA3C5815-6D9C-4FBF-8F82-C0A97BD02943

P2860

Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.

Item

http://www.wikidata.org/entity/Q47736389

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Clinical Impact and Risk Facto ...... ly Non-small Cell Lung Cancer.

@en

Clinical Impact and Risk Facto ...... ly Non-small Cell Lung Cancer.

@nl

type

Item

label

Clinical Impact and Risk Facto ...... ly Non-small Cell Lung Cancer.

@en

Clinical Impact and Risk Facto ...... ly Non-small Cell Lung Cancer.

@nl

prefLabel

Clinical Impact and Risk Facto ...... ly Non-small Cell Lung Cancer.

@en

Clinical Impact and Risk Facto ...... ly Non-small Cell Lung Cancer.

@nl

P1476

Clinical Impact and Risk Facto ...... ly Non-small Cell Lung Cancer.

@en

P2093

Fumihiko Hirai

http://www.w3.org/2001/XMLSchema#string

Fumihiko Kinoshita

http://www.w3.org/2001/XMLSchema#string

Fumihiro Shoji

http://www.w3.org/2001/XMLSchema#string

Gouji Toyokawa

http://www.w3.org/2001/XMLSchema#string

Hiroshi Honda

http://www.w3.org/2001/XMLSchema#string

Kazuki Takada

http://www.w3.org/2001/XMLSchema#string

Masakazu Katsura

http://www.w3.org/2001/XMLSchema#string

Mototsugu Shimokawa

http://www.w3.org/2001/XMLSchema#string

Naoki Haratake

http://www.w3.org/2001/XMLSchema#string

Shinkichi Takamori

http://www.w3.org/2001/XMLSchema#string

P2860

Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People

Increasing physical activity and exercise in lung cancer: reviewing safety, benefits, and application

High CO2 levels cause skeletal muscle atrophy via AMP-activated kinase (AMPK), FoxO3a protein, and muscle-specific Ring finger protein 1 (MuRF1).

Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer

Loss of Skeletal Muscle Mass During Neoadjuvant Chemoradiotherapy Predicts Postoperative Mortality in Esophageal Cancer Surgery.

Clinical impact of postoperative loss in psoas major muscle and nutrition index after radical cystectomy for patients with urothelial carcinoma of the bladder

Loss of skeletal muscle during neoadjuvant chemotherapy is related to decreased survival in ovarian cancer patients.

Prevalence and prognostic effect of sarcopenia in breast cancer survivors: the HEAL Study.

The emerging role of computerized tomography in assessing cancer cachexia.

Nutrition and physical activity for the prevention and treatment of age-related sarcopenia.

P2888

s10434-017-6328-y

P31

scholarly article

P356

10.1245/S10434-017-6328-Y

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1100337635

http://www.w3.org/2001/XMLSchema#string

P698

29327178

http://www.w3.org/2001/XMLSchema#string

Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.

about

P2860

P2860

Clinical Impact and Risk Factors for Skeletal Muscle Loss After Complete Resection of Early Non-small Cell Lung Cancer.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P31

P356

P577

P6179

P698